Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial

BACKGROUND: The World Health Organization (WHO) recently recommended the addition of a single low-dose of the gametocytocidal drug primaquine (PQ) to artemisinin-based combination therapy (ACT) in low transmission settings as a component of pre-elimination or elimination programmes. However, it is u...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Malar J
Main Authors: Mwaiswelo, Richard, Ngasala, Billy, Jovel, Irina, Aydin-Schmidt, Berit, Gosling, Roland, Premji, Zul, Mmbando, Bruno, Björkman, Anders, Mårtensson, Andreas
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2016
נושאים:
Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5002101/
https://ncbi.nlm.nih.gov/pubmed/27565897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-016-1430-3
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים